Nominees 2025

Discover the brilliance behind the deals: unveiling the nominees for the M&A Awards 2025.
Read the press release here.

Nominees Best Large Cap Corporate Deal 2025

Ageas acquires Esure


Jury motivation

The Ageas–esure deal is a landmark £1.295 billion acquisition that creates the third-largest UK personal lines insurer. It perfectly fits Ageas’s Elevate27 strategy, reinforcing its European growth and digital ambitions. The combination strengthens Ageas’s UK presence and diversifies distribution across multiple channels. The transaction is expected to deliver over £100 million (€115 million) in annual pre-tax synergies, enhancing group cash generation, profitability, and capital efficiency. Executed with remarkable speed and precision in a highly competitive auction, the deal exemplifies strategic vision, flawless execution, and transformative impact. It demonstrates how disciplined leadership and clear strategic focus can turn an ambitious move into a value-creating success — a textbook example of a large-cap transaction that sets new market standards.

CMB.Tech and Golden Ocean merge


Jury motivation

The merger unites two global leaders into one of the world’s largest and most diversified maritime groups, operating a fleet of 250 vessels. It combines CMB.TECH’s clean-energy innovation with Golden Ocean’s market-leading dry bulk operations. The resulting company has a €2.64 billion market cap and $4.4 billion NAV, strengthening its global standing. Over one-third of the fleet is hydrogen- and ammonia-ready, positioning the company at the forefront of maritime decarbonization. The transaction accelerates diversification and sustainability while improving liquidity through triple listings on NYSE, Euronext Brussels, and Euronext Oslo. The Saverys family’s visionary leadership and flawless cross-border execution redefined the sector — a transformative merger that combines scale, sustainability, and strategic excellence.

Sonaca acquires Aciturri Aerostructure


Jury motivation

This deal unites Sonaca’s aluminum expertise with Aciturri’s carbon composite mastery to create Europe’s third-largest independent aerostructures company, with 6,500 employees and €1.2 billion in projected turnover. It marks a key step toward greener aviation and stronger European defense independence. Negotiated over four years, including the COVID crisis, the acquisition demanded perseverance to overcome major regulatory and financial challenges. Sonaca succeeded in acquiring one of Spain’s most valuable industrial players, driven by vision and resilience. The partnership embodies true European ambition — combining sustainability, defense strength, and industrial renewal. Thanks to Yves Delatte and Ginés Clemente, what once seemed impossible became a defining success for Europe’s aerospace future.

Nominees Best Mid Cap Corporate Deal 2025

Arrive acquires Be-Mobile


Jury motivation

The sale of Be-Mobile by Proximus stands out as one of this year’s defining mid-market deals. It fits within Proximus’s broader divestment program to focus on fiber investments — and was even a cornerstone of that strategy. Adding to the complexity, the transaction was executed during a CEO transition at Proximus. The deal unfolded in two steps: first, Proximus sold its 92.7% stake in Be-Mobile for €175 million to Vitruvian and portfolio company Arrive. Then, Be-Mobile was split in two: the 4411 parking service went to Arrive, while traffic and smart city activities continued independently under CEO Jan Cools. A challenging, multi-layered process — delivered with precision and strategic clarity.

Hexagon acquires Septentrio


Jury motivation

Leuven-based Septentrio, a spin-off from imec, is a global leader in precision navigation technology — similar to GPS but accurate to the centimeter. Its GNSS systems serve robotics, industrial automation, and other advanced sectors. After years as an independent company, Septentrio was acquired by Sweden’s Hexagon following a competitive international process. The deal was anything but standard, involving diverse shareholders, operations in six countries, and sensitive intellectual property. It represents a strategic move reinforcing Hexagon’s expertise in high-precision geodata — notably, it had already acquired Leuven-based Luciad eight years earlier. This acquisition highlights Belgium’s excellence in deep-tech innovation and Hexagon’s long-term commitment to precision technology.

Specialist Risk Group acquires Ecclesia’s Dutch and Belgian operations


Jury motivation

A deal with a spiritual twist — SRG’s acquisition of IC Verzekeringen and Concordia marks a rare transaction involving the Catholic Church’s insurance arm. Through this deal, the UK-based Specialist Risk Group entered the Belgian market, as part of a broader cross-border transaction with German parent Ecclesia. SRG acquired Ecclesia’s Belgian and Dutch operations, while Ecclesia became a shareholder in SRG, deepening their partnership. The deal showcases sophisticated structuring and regulatory execution, combining strategic entry, reciprocal investment, and cultural sensitivity. It underlines the growing consolidation among European insurance brokers and demonstrates SRG’s ambition to expand across continental Europe while respecting local legacy and values.

Nominees Best Large Cap Private Equity Exit 2025

Bencis Capital Partners and shareholders partially exit Equine Care Group


Jury motivation

Bencis Capital Partners transformed Equine Care Group into a pioneering veterinary platform achieving €100 million turnover in under five years — a textbook case of accelerated value creation. The strategic partial exit to CNP secures long-term global growth while preserving ECG’s vet-led model, ensuring lasting impact on equine welfare. The transaction required an innovative structure to align complex ethical frameworks with investor returns and management participation. Equally impressive is the leadership of the founders, whose vision turned a fragmented industry into a global platform. This deal checks every box — vision, execution, and value creation — showing how purpose and performance can successfully coexist in large-cap private equity.

Gimv, SFPIM, PMV, Alychlo and Smartfin exit Itineris


Jury motivation

Over the past decade, Itineris evolved from a local software specialist into a transatlantic leader, supported by a strong Belgian investor base. The sale to Cobepa secures fresh capital and expertise to accelerate its journey toward global leadership in utility software. The competitive process ensured continuity, with founder Edgard Vermeersch remaining significantly invested. The partnership with Cobepa enables Itineris to modernize utilities worldwide, driving digital transformation across critical infrastructure. This deal demonstrates strategic alignment between founder and investors, ensuring both growth and stability. It also underlines the strength of Belgium’s tech ecosystem, capable of scaling innovative solutions to the global stage.

Think2Act exits Boma


Jury motivation

Under Think2Act’s ownership, BOMA nearly doubled in size to reach €145 million turnover, evolving into a market leader in professional cleaning solutions. Offering strong proprietary brands such as BOMA and Greenspeed, complemented by digital tools and advanced logistics, the company achieved both innovation and operational excellence. The partial exit to IK Partners secures a clear European buy-and-build strategy for rapid cross-border expansion. Importantly, founding shareholders and management remain significantly invested, ensuring continuity and alignment. The leadership’s authenticity and long-term vision stand out — building a resilient, sustainable business ready for its next European chapter. A model example of value creation through partnership and foresight.

Nominees Best Mid Cap Private Equity Exit 2025

3d Investors and ING Corporate Investments exit 3P


Jury motivation

3P provides public-sector clients with software for digital tendering and contract automation. With >99% recurring revenue and strong customer retention, it became a robust platform for sustainable growth. Backed by 3d Investors and ING Corporate Investments since 2016, 3P scaled from startup to market leader, diversified products, and entered France while maintaining its core position in Belgium. The sale to Eurazeo introduces a new phase of international expansion. Eurazeo’s European DNA, deep sector expertise, and cross-border M&A capability make it the ideal partner. All stakeholders — founders, investors, and management — reinvested, ensuring alignment. A benchmark exit for strategic continuity and European growth.

Fortino Capital partially exits Cenosco


Jury motivation

Fortino’s partial exit from Cenosco is a textbook example of a well-executed buyout trajectory culminating in an excellent outcome. Since Fortino’s 2020 investment, Cenosco has doubled revenue and staff through organic growth, transforming from a consultancy reliant on one client to a software company with 75% recurring revenue. The reshaped management team — new CEO, HR, and CFO — professionalized operations and attracted global buyers. The final buyer, Summit Partners, brings U.S. reach and expertise to accelerate expansion. This transaction demonstrates disciplined execution, value creation, and strategic foresight — turning a niche software player into an international growth platform.

Sofindev exits Companyweb


Jury motivation

Companyweb, a leading provider of business and credit information, was sold by Sofindev and management to Altares Dun & Bradstreet, backed by Naxicap Partners. Sofindev’s 2018 buyout transformed the company into a scalable SaaS platform with strong recurring revenues, high retention, and a modern technology backbone. Companyweb more than doubled organically, while Sofindev enabled a co-founder’s exit and continuity under the CEO. Altares was the preferred buyer thanks to its strategic fit and commitment to autonomy and growth. The deal delivered outstanding returns and sustainable stakeholder value — a prime example of strategic clarity, collaborative governance, and disciplined execution in the Belgian mid-cap landscape.

Nominees Best Venture Capital Deal – Technology 2025

Aerospacelab raises a funding round


Jury motivation

Aerospacelab impressed the jury with its €94 million funding round — combining a €56 million Series B extension and a €38 million European Investment Bank loan. Founded in 2018, the company has become a key player in Europe’s New Space sector. By 2027, it will open a groundbreaking Megafactory in Charleroi, capable of producing 500 satellites per year. The investment strengthens Europe’s strategic autonomy and meets rising global demand for satellite constellations. CEO Benoît Deper’s visionary leadership, focus on vertical integration, and cost-efficient manufacturing continue to drive innovation and growth. A defining milestone for Belgium’s tech ecosystem and European space ambitions.

Nobi raises a Series B funding round


Jury motivation

Nobi, the Belgian AgeTech innovator, successfully closed an oversubscribed €35 million Series B round led by specialized venture investors and supported by existing shareholders. The funding underscores growing global demand for AI-driven solutions addressing aging populations. Nobi’s signature innovation — a stylish, intelligent lamp equipped with optical sensors and AI — offers seamless monitoring and safety for older adults, blending care and design. The company exemplifies how technology can deliver dignity and independence. With this milestone, Nobi reinforces its international growth ambitions and leadership in AgeTech innovation, proving that smart care can also be beautiful and human-centered.

Swave Photonics raises a Series A funding round


Jury motivation

Swave Photonics, a Belgian semiconductor pioneer spun out from imec, raised €33 million in Series A funding led by imec.xpand and SFPIM Relaunch, joined by IAG Capital and Samsung Ventures. Using its proprietary holographic chips, Swave develops technology that creates lifelike 3D images visible to the naked eye. The company aims to power the next evolution of spatial computing — where users interact with digital content through smart glasses rather than screens. This landmark round validates Belgium’s leadership in deep-tech and photonics innovation and supports Swave’s ambition to redefine immersive computing on a global scale.

Nominees Best Venture Capital Deal – Life Sciences 2025

AgomAb raises a Series D funding round


Jury motivation

Agomab Therapeutics closed an $82 million Series D round in November 2024, attracting new investors Sanofi and Invus alongside existing backers Boehringer Ingelheim and Pfizer. The round, completed in just over a month, highlights strong investor confidence and Agomab’s scientific credibility. Funds will advance its clinical pipeline, expand its workforce, and strengthen its cash position, ensuring strategic flexibility. Agomab retains full commercial rights, preserving long-term value. The transaction solidifies Agomab’s position as a key European biotech player and underscores Belgium’s global relevance in life sciences innovation — demonstrating how scientific excellence, execution speed, and strategic independence can coexist successfully.

AstraZeneca acquires EsoBiotec


Jury motivation

AstraZeneca’s acquisition of Belgian biotech EsoBiotec, worth up to $1 billion ($425 million upfront and $575 million in milestones), highlights global confidence in Belgium’s cell therapy innovation. EsoBiotec’s technology promises scalable, cost-effective solutions that could make cell therapy accessible to far more patients. The deal aligns with AstraZeneca’s mission to advance next-generation immunotherapies and strengthens its leadership in cutting-edge treatments. It also underlines the maturity of Belgium’s biotech ecosystem and the pivotal role of regional investors in supporting globally relevant startups. A transformative transaction combining science, scale, and purpose.

The acquisition also underscores the growing maturity and global significance of Belgium’s biotech ecosystem, as well as the crucial role played by regional investors in supporting high-impact startups.

ATB therapeutics raises a Series A funding round


Jury motivation

ATB Therapeutics successfully closed a €54 million Series A round led by EQT Life Sciences and MRL Ventures Fund (Merck & Co.), supported by Belgian public and private investors. This strong syndicate combines global reach with local ecosystem depth. The funding validates ATB’s proprietary ATBioFarm platform, which holds transformative potential in oncology and immunology. The proceeds will advance clinical programs and expand operations in Ghent and Marche-en-Famenne, where a state-of-the-art pilot manufacturing facility is being developed. The deal showcases world-class science, strong investor alignment, and Belgium’s growing influence in global biotech.

Lifetime Achievement Award 2025

For the Lifetime Achievement Award, introduced in 2023, we don’t announce any nominees. The winner will be revealed and celebrated during the gala evening.